data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Cogent Biosciences
(NASDAQ:COGT)
$10.90
At close: Jul 6
$11.15
0.25[2.29%]
PreMarket: 6:34PM EDT
Day High/Low- - -
52 Week High/Low3.79 - 11.19
Open / Close- / -
Float / Outstanding62.1M / 63.7M
Vol / Avg.- / 2.9M
Mkt Cap694.5M
P/E-
50d Avg. Price6.53
Div / Yield-
Payout Ratio-
EPS-0.68
Total Float62.1M

Cogent Biosciences (NASDAQ:COGT), Quotes and News Summary

Cogent Biosciences (NASDAQ: COGT)

Day High/Low- - -
52 Week High/Low3.79 - 11.19
Open / Close- / -
Float / Outstanding62.1M / 63.7M
Vol / Avg.- / 2.9M
Mkt Cap694.5M
P/E-
50d Avg. Price6.53
Div / Yield-
Payout Ratio-
EPS-0.68
Total Float62.1M
Benzinga - Jun 28, 2022, 7:30AM
Benzinga - Jun 13, 2022, 6:07AM
Benzinga - Jun 13, 2022, 5:24AM
Benzinga - Jun 10, 2022, 12:27PM
Benzinga - Jun 10, 2022, 11:14AM
Benzinga - Jun 10, 2022, 11:14AM
Benzinga - Jun 10, 2022, 9:09AM
Benzinga - Jun 10, 2022, 7:01AM
Benzinga - Jun 10, 2022, 7:01AM
Benzinga - May 10, 2022, 7:44AM
Benzinga - Nov 10, 2021, 7:35AM
Benzinga - Nov 5, 2021, 1:05PM
Benzinga - Nov 5, 2021, 12:54PM
Benzinga - Oct 11, 2021, 6:14AM
Benzinga - Oct 1, 2021, 7:02AM
Benzinga - Aug 16, 2021, 7:24AM
Benzinga - Aug 9, 2021, 8:54AM
Sector: Health Care.Industry: Biotechnology
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-15
REV
Q1 2022Est.ActualSurprise
EPS-0.520-0.680 -0.1600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Cogent Biosciences Questions & Answers

Q
How do I buy Cogent Biosciences (COGT) stock?
A

You can purchase shares of Cogent Biosciences (NASDAQ: COGT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Cogent Biosciences's (COGT) competitors?
Q
What is the target price for Cogent Biosciences (COGT) stock?
A

The latest price target for Cogent Biosciences (NASDAQ: COGT) was reported by Guggenheim on Tuesday, June 28, 2022. The analyst firm set a price target for 15.00 expecting COGT to rise to within 12 months (a possible 37.61% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Cogent Biosciences (COGT)?
A

The stock price for Cogent Biosciences (NASDAQ: COGT) is $10.9 last updated July 6, 2022, 8:00 PM UTC.

Q
Does Cogent Biosciences (COGT) pay a dividend?
A

There are no upcoming dividends for Cogent Biosciences.

Q
When is Cogent Biosciences (NASDAQ:COGT) reporting earnings?
A

Cogent Biosciences’s Q2 earnings are confirmed for Monday, August 15, 2022.

Q
Is Cogent Biosciences (COGT) going to split?
A

There is no upcoming split for Cogent Biosciences.

Q
What sector and industry does Cogent Biosciences (COGT) operate in?
A

Cogent Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.